Order Article Reprints

Hoekstra M, de Jong LM, van der Geest R, de Leeuw LR, Krisnamurthi R, Geerling JJ, Van Eck M. LXR Agonist T0901317′s Hepatic Impact Overrules Its Atheroprotective Action in Macrophages, Driving Early Atherogenesis in Chow-Diet-Fed Male Apolipoprotein E Knockout Mice. Biomolecules. 2024; 14(4):429. https://doi.org/10.3390/biom14040429

Hoekstra, Menno, Laura M. de Jong, Rick van der Geest, Lidewij R. de Leeuw, Rani Krisnamurthi, Janine J. Geerling, and Miranda Van Eck. 2024. "LXR Agonist T0901317′s Hepatic Impact Overrules Its Atheroprotective Action in Macrophages, Driving Early Atherogenesis in Chow-Diet-Fed Male Apolipoprotein E Knockout Mice" Biomolecules 14, no. 4: 429. https://doi.org/10.3390/biom14040429

Hoekstra, M., de Jong, L. M., van der Geest, R., de Leeuw, L. R., Krisnamurthi, R., Geerling, J. J., & Van Eck, M. (2024). LXR Agonist T0901317′s Hepatic Impact Overrules Its Atheroprotective Action in Macrophages, Driving Early Atherogenesis in Chow-Diet-Fed Male Apolipoprotein E Knockout Mice. Biomolecules, 14(4), 429. https://doi.org/10.3390/biom14040429